Sanfilippo Children's Foundation

What Sanfilippo Children's Foundation does

Sanfilippo Children's Foundation was an Australian-registered non-profit charitable foundation established in 2014 to fund research and provide support for families affected by Sanfilippo syndrome, a rare genetic condition causing fatal childhood dementia for which no treatment or cure exists. The Foundation operated a competitive annual research grant program, ultimately directing over $7.5 million to 41 research projects spanning gene therapy, enzyme replacement, drug repurposing, and other therapeutic approaches, while building an international research network across 14 countries. Beyond grant-making, it developed first-mover assets including the Brain in a Dish research platform, the first-ever global clinical care guidelines for Sanfilippo, the Global Roadmap for Sanfilippo Syndrome Therapies, and a patient registry connecting families with clinical trials. The Foundation also co-founded the International Sanfilippo Syndrome Alliance, ran the annual Solving Sanfilippo Symposium, and operated a Family Advocate's Program.

The Foundation generated all of its revenue through donations, fundraising events, family campaigns, and one-off grants such as a $2 million award from the Australian Commonwealth Government's Medical Research Future Fund. It reached supporters through a website, email newsletter, organic social media, earned media across major Australian outlets (Network 10's The Project, ABC Radio National, 60 Minutes Australia), a TEDx talk, and community events including Hike for Hope treks. Its customer-facing programs targeted families affected by Sanfilippo and the broader rare-disease donor community. In January 2025, the Foundation announced it would cease operating as a separate entity, with its mission transferred to the Childhood Dementia Initiative, an organization established in 2020 by founder Megan Donnell to address all childhood dementia disorders. The small team of three completed its wind-down work in late January 2025, and the Foundation is now closed as an operating entity.

Name

Sanfilippo Children's Foundation

Legal name

Sanfilippo Children's Foundation

Website

https://sanfilippo.org.au

Company type

Private

Founded year

2014

Operating status

Closed

Headcount range

1–10 employees

Short description

Sanfilippo Children's Foundation was an Australian non-profit (founded 2014, closed January 2025) that directed over $7.5 million to 41 Sanfilippo syndrome research projects, built a 14-country research network, and produced the first global clinical care guidelines before transferring its mission to the Childhood Dementia Initiative.

Ownership category

akta.pro rank

Product category

Rare Disease Research Foundation

NAICS

Grantmaking Foundations (813211), Voluntary Health Organizations (813212), Child and Youth Services (62411)

SIC

Services-Social Services (8300)

akta.pro primary industry

Health & Medical Research Grantmaking Foundations (BPAGAKAL)

akta.pro secondary industries

Private Foundations (BPAGAKAA), Community Health & Prevention Program Funding (HLAJALAF)

Keywords

• Rare disease research
• Childhood dementia research
• Nonprofit charitable foundation
• Medical research funding
• Patient advocacy services

Headquarters

HQ city

Freshwater

HQ country

Australia

HQ region

Oceania

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

1. Donations and Fundraising: The Foundation generates revenue entirely through donations from individuals, families, and supporters. This includes one-time donations, event registrations, fundraising campaign contributions, and ongoing supporter engagement.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels6 records

Core offering

Sanfilippo Children's Foundation is a non-profit charitable organization that funds scientific research into Sanfilippo syndrome, a rare genetic condition causing fatal brain damage in children. The Foundation operates an annual competitive research grant program, maintains a portfolio of funded research projects, provides a patient registry connecting families with clinical trials, and delivers family support and awareness programs. Revenue is generated entirely through donations from individuals, families, and supporters.

Product overview

Sanfilippo Children's Foundation is a nonprofit charitable organization that serves as a centralized hub for Sanfilippo syndrome research funding and family support. The Foundation operates a competitive annual research grant program funding projects globally, maintains a portfolio of over 41 funded research initiatives, and provides patient registry services connecting families with clinical trials. Core programs include the Global Research Roadmap strategic initiative, Solving Sanfilippo Symposium annual meeting, Family Campaigns storytelling program, and various fundraising events. The Foundation also developed the Brain in a Dish research platform and published the first-ever global clinical care guidelines for Sanfilippo.

Differentiator

Problem solved

Functional benefit

Products and services

• Research Funding Program Annual competitive research grant program funding scientific projects focused on Sanfilippo syndrome treatments and cure development, open to researchers and institutions globally.
• Funded Projects Portfolio Portfolio of 41 funded research projects totaling over $7.5 million, spanning gene therapy, enzyme replacement, drug repurposing, and other therapeutic approaches for Sanfilippo syndrome.
• Patient Registry Registry connecting Sanfilippo patients with clinical trials and providing data for research purposes, supporting affected families and researchers.
• Global Research Roadmap for Sanfilippo Syndrome Therapies Strategic document outlining priorities for Sanfilippo syndrome therapy development, created in collaboration with international researchers and organizations.
• Brain in a Dish Research Platform Innovative research platform developing cell models from Sanfilippo patients to study disease mechanisms and screen potential treatments.
• Sanfilippo Clinical Care Guidelines First-ever global clinical care guidelines for Sanfilippo syndrome, developed to standardize patient care across international healthcare providers.
• Solving Sanfilippo Symposium Annual scientific meeting bringing together researchers, clinicians, and families to advance Sanfilippo research collaboration.
• Family Campaigns Personal stories and fundraising campaigns featuring children affected by Sanfilippo syndrome to raise awareness and research funds.
• Events & Fundraisers Various fundraising events including Hike for Hope treks, charity challenges, and community activities to support Sanfilippo research.

Named customers1 record

Segments1 record

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Seven partnerships are on record, tiered core, major and minor.

• Childhood Dementia InitiativecoreStrategic or Co-development Partner · 1 January 2020Founded in 2020 by former Sanfilippo Children's Foundation CEO Megan Donnell (formerly Donnell), who is a parent of two children with Sanfilippo. The Foundation's mission was transitioned to Childhood Dementia Initiative in January 2025 to better meet the needs of the Sanfilippo community in a sustainable way.
• Cure Sanfilippo Foundation (USA)coreStrategic or Co-development PartnerCo-funding research projects including Professor Pshezhetsky's work on combination therapies and Professor Hemsley's drug repurposing project for attenuated Sanfilippo.
• Sanfilippo Fighters (Italy)coreStrategic or Co-development PartnerCo-funding Dr Emma Parkinson-Lawrence's project on repurposing azithromycin for recurrent lung infections in Sanfilippo type A.
• Brain Foundation (Australia)majorStrategic or Co-development PartnerCo-funding Dr Karissa Barthelson's project comparing familial Alzheimer's disease and Sanfilippo syndrome at single-cell resolution.
• International Sanfilippo Syndrome AlliancecoreStrategic or Co-development PartnerCo-founded international alliance to advance Sanfilippo research globally.
• H.A.N.D.S ConsortiumminorStrategic or Co-development PartnerCo-funding additional research projects in the Sanfilippo field.
• Dementia Support AustraliaminorStrategic or Co-development PartnerCollaboration on behavioral symptoms research for children with Sanfilippo, implementing person-centred care strategies.

Scale indicators5 records

Recent moves7 records

Expansion highlights4 records

Direct peers

• Cure SMA: US-based non-profit that funds Spinal Muscular Atrophy research and family support, with a successful record of translating research funding into approved gene therapies. Comparable as a rare pediatric disease foundation with a similar research-funding and family-support operating model.
• Sanfilippo Fighters: Italy-based non-profit dedicated to Sanfilippo syndrome research funding. Directly comparable as a single-disease rare-disease foundation that has co-funded specific projects with Sanfilippo Children's Foundation.
• Jonah's Just Begun Foundation: US-based non-profit focused on Sanfilippo type C research, including chaperone therapy studies. Directly comparable as a sub-type-specific rare-disease foundation that has co-funded research with the subject Foundation.
• Cure Sanfilippo Foundation: US-based non-profit focused specifically on funding Sanfilippo syndrome research. Directly comparable as a single-disease rare-disease foundation co-funding the same researcher projects (e.g., Professor Pshezhetsky's combination therapies).
• Batten Disease Support & Research Association: Non-profit funding research and supporting families affected by Batten disease, another fatal neurodegenerative lysosomal storage disorder in children. Directly comparable mission and operational model in ultra-rare pediatric neurodegenerative disease.
• Project ALS: Non-profit funding research into ALS and related neurodegenerative diseases. Comparable as a mission-driven rare neurodegenerative disease foundation with a research-grant-making operating model.

Emerging players

• Childhood Dementia Initiative: Australia-based non-profit founded in 2020 by the same founder as Sanfilippo Children's Foundation to address all childhood dementia disorders. The successor organization absorbing the Foundation's mission in January 2025.

Broad incumbents

• National MPS Society: US-based non-profit supporting individuals and families affected by MPS (Mucopolysaccharidoses) and related lysosomal storage diseases, which include Sanfilippo (MPS III). Comparable as a broader rare-disease umbrella foundation in the same therapeutic area.
• Children's Tumor Foundation: Major US-based non-profit funding research into neurofibromatosis. Comparable as an established rare pediatric disease research foundation with a multi-decade operating history and broad donor base.

Regional players

• Rare Diseases South Africa: South Africa-based non-profit supporting individuals and families affected by rare diseases. Comparable as a regional rare-disease advocacy and support organization, though broader in scope than Sanfilippo specifically.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/sfcfoundtn
• Facebookfacebook.com/sanfilippochildrensfoundation

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Sanfilippo Children's Foundation